IU, Purdue among top U S patent recipients wishtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wishtv.com Daily Mail and Mail on Sunday newspapers.
The COVID-19 Vaccine Patent Waiver Fight Is Far From Over
The waiver s timing and scope, plus the transfer of technological know-how and development of manufacturing infrastructure, will all be fiercely debated.
Getty Images
President Joe Biden and U.S. Trade Representative Katherine Tai are under industry pressure to make a COVID-19 vaccine intellectual property waiver as narrow as possible.
The Biden administration’s announcement last Wednesday that it planned to support waiving intellectual property (IP) protections for COVID-19 vaccines prompted praise from global public health advocates and outcry from the pharmaceutical industry and corporate America more broadly.
But the historic statement of support, issued by U.S. Trade Representative Katherine Tai, does not make the waiver a done deal. Even if successful, the availability of vaccines could vary greatly based on the final details of the waiver.
POLITICO
Get the POLITICO Influence newsletter
Email
Sign Up
By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Presented by
With Daniel Lippman
PHARMA, MANUFACTURERS BLAST ADMINISTRATION OVER VACCINE PATENT WAIVERS: The Biden administration on Wednesday reversed course and said it supports waiving patent and other intellectual property protections for Covid-19 vaccines in a bid to ramp up production of the shots around the globe a victory for progressives who had pressured the administration and potentially a major blow for the pharmaceutical industry, which had lobbied heavily against the waiver.
Mon, May 3rd 2021 9:30am
Mike Masnick
Throughout the COVID pandemic, it s been truly shameful to watch how patent maximalists have tried to insist that we just need more patents to deal with COVID even though the incredible breakthroughs that brought such quick development of vaccines were not due to patents, but rather the free and open flow of information from a bunch of researchers and scientists who didn t care about whether or not information was locked up for profit, but did care
about saving millions of lives.
And now that we ve got vaccines, we re dealing with significant problems in rolling them out around the world and patents are often in the way, holding that rollout back. And we actually have a way of dealing with that: what s known as a TRIPS waiver. TRIPS is the Agreement on Trade-Related Aspects of Intellectual Property Rights, which set up a variety of standards among member nations and the WTO regarding intellectual property. I have many problems with TRI